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Abstract 
Experimental and theoretical charge density analyses of piroxicam (1), saccharin (2) and their 
1:1 co-crystal complex (3) have been carried out. Electron density distribution (EDD) was 
determined through the use of high-resolution single crystal X-ray diffraction and the data 
were modelled using the conventional multipole model of electron density according to the 
Hansen-Coppens formalism. A method for optimising the core density refinement of sulfur 
atoms is discussed, with emphasis on the reduction of residual electron density that is 
typically associated with this atom. The asymmetric unit of complex (3) contains single 
molecules of saccharin and the zwitterionic form of piroxicam. These are held together by 
weak interactions (hydrogen bonds, π-π and van der Waals interactions), ranging in strength 
from 4 to 160 kJmol-1, working together to stabilise the complex;. analysis of the molecular 
electrostatic potential (MEP) of the complexes showed electron redistribution within the co-
crystal, facilitating the formation of these generally weak interactions. Interestingly, in the 
zwitterionic form of piroxicam, the charge distribution reveals that the positive and negative 
charges are not associated with the formal charges normally associated with this description, 
but are distributed over adjacent molecular fragments. The use of anisotropic displacement 
parameters (ADPs) for hydrogen atoms in the multipole model was also investigated but no 
improvement in the quality of the topological analysis was found.  
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Introduction 
Piroxicam, commercially known as Feldene or Mobili, is a non-steroidal anti-inflammatory 
drug (NSAID) and is used for a wide range of indications including rheumatoid arthritis, 
osteoarthritis and various other superficial sporting injuries1. Its mechanism of action is the 
non-selective inhibition of the cycloxygenase (COX) 1 and 2 pathways to inhibit the 
production in prostaglandins involved in inflammatory and pain responses in response to 
injury. The non-selective inhibition exhibited by piroxicam results in an unfavourable adverse 
effect profile, with one of the more pressing issues being gastrointestinal (GI) damage via 
disruption of the integrity of the gastric mucosa and prevention of its regeneration2. This has 
been one of the major reasons for piroxicam being less commonly prescribed than selective 
COX 2 inhibitors such as meloxicam, which has more favourable adverse effect profiles.  
A potential solution to this problem was raised in 2013 via the use of an inclusion complex 
(piroxicam-β-Cyclodextrin)2, which was found to have less GI side effects compared to free 
piroxicam. Co-crystallisation is a similar solution to the problem and has previously been 
investigated by Banerjee et al. through the piroxicam-saccharin co-crystal3, which has been 
found to modify the physicochemical properties of piroxicam compared to free piroxicam. 
The development of an economically viable and universal method to improve 
physicochemical properties of an active pharmaceutical ingredient (API) without changing its 
activity has been at the forefront of research in the pharmaceutics area and has garnered 
widespread interest from both academia and industry.4 Co-crystals, defined as crystals 
composed of two or more components that are solid at room temperature5 and pharmaceutical 
co-crystals where one of the components is an API are believed by many to be a viable and 
cost effective solution to this problem.  
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Pharmaceutical co-crystals, by improving physicochemical, pharmacokinetic and 
pharmacodynamics properties of APIs will allow pharmaceutical companies to bring more 
drugs to the market in a shorter period of time. This significantly reduces research and design 
costs, particularly as poor physicochemical properties (such as solubility, dissolution rate, 
bioavailability, chemical stability, and hygroscopicity) are the primary reason for over 80% 
of APIs failing to reach the market.6 Furthermore, improved physicochemical properties will 
allow drugs to be made into more acceptable dose forms such as tablets and this will lead to 
increased adherence and subsequently improved patient health outcomes. Moreover, novel 
formulations which allow new patents or to extend the life of older patents are of great 
interest to pharmaceutical companies. Co-crystals are considered to fulfil all the criteria for 
patentability, namely novelty, utility and non-obviousness,4, 7 even though the API is 
identical.  
This paper aims to examine the abovementioned co-crystal at the electronic level to 
determine the mechanism behind the change in physicochemical activity of the co-
crystallised piroxicam compared to its free form. Nguyen et al. recently published research 
regarding the use of density functional theory (DFT) and atoms in molecules (AIM) theory8 
to analyse EDD in experimental and theoretical models to examine weak interactions such as 
hydrogen bonds (HBs), π-π stacking and van der Waals interactions present in biologically 
significant systems, including host-receptor complexes.9, 10 They concluded that an increased 
understanding of the electron and hence energy distribution in such interactions will lead to 
continued improvements in the drug design and development process, potentially resulting in 
the development of more efficacious and less toxic therapeutics. Following on from these 
benefits offered by pharmaceutical co-crystals in the development of efficacious and non-
toxic therapeutics, a more detailed look at the weak interactions between API and co-former 
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within a crystalline environment via an EDD study is warranted to increase our knowledge of 
the interactions present, and to optimise co-crystal prediction programs in the future. 	  
Here we report on the EDD of these weak interactions present in individual crystals of 
piroxicam (1) and saccharin (2), and a comparison between a piroxicam–saccharin co-crystal 
(3), in which the asymmetric unit contains one zwitterionic piroxicam and one saccharin 
molecule. Analysis of the intermolecular bond energies is also presented in in an effort to 
classify key interactions specific to this co-crystal system.  
 
Figure 1 Structures of Piroxicam (1) and Saccharin (2). 
Previous studies, including those of a crystallographic nature, have previously been carried 
out on complexes 1,3, 11 212 and 3,13 but none has involved EDD studies. It is believed that the 
latter will provide further information on the interactions which consistently form in the 
presence of particular functional groups i.e. supramolecular synthons.14, 15 Specifically, these 
interactions play a key role in the formation and stabilisation of co-crystal systems via 
molecular recognition,16 and also aid in the engineering and development of more efficacious 
and non-toxic therapeutics.  
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Figure 2: ORTEP diagram of piroxicam (1). Thermal ellipsoids are shown at 50% probability 
level17.  
 
Figure 3: ORTEP diagram of saccharin (2). Thermal ellipsoids are shown at 50% probability 
level17.
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Figure 4: ORTEP diagram of the piroxicam-saccharin co-crystal (3). Thermal ellipsoids are 
shown at 50% probability level17. 
Methods 
Crystal preparation 
Compounds purchased from Sigma-Aldrich and used without further purification. Crystals 
(1) and (2) were obtained via slow evaporation from acetone. Crystals of (3) were obtained 
following the method described by Banerjee et al 3, from a mixture of equimolar amounts of 
(1) and (2) dissolved in a 1:1 mixture of CHCl3 : MeOH, which was  slowly evaporated. 
 
Data Collection, Integration and Reduction  
Single-crystal X-ray diffraction experiments were carried out in the Faculty of Pharmacy at 
8	  	  
the University of Sydney using an Agilent SuperNova™ X-ray diffractometer with an X-ray 
wavelength of 0.7107 Å (MoKα) at 100K. Crystals of (1), (2) and (3) with dimensions (0.30 x 
0.20 x 0.20) mm, (0.25 x 0.25 x 0.20) mm and (0.25 x 0.20 x 0.20) mm, respectively, were 
mounted on thin glass fibres with Paratone-N oil being used as both adhesive and 
cryoprotectant. Data were collected for all crystals using 1° ω scans maintaining the crystal-
to-detector distance at 5.2 cm for (1) and 5.3 cm for (2) and (3). For (1) and (2), reciprocal 
space coverage was achieved during the data collection by positioning the detector arm at two 
different angles in 2θ, 41.5° and 90.5°. Exposure times of 6 and 24 seconds were used for (1), 
20 and 65 seconds for (2) respectively. Reciprocal space was covered in (3) via positioning 
the detector arm at 41.5° and 72° in 2θ, with exposure times of 8 and 45 seconds per frame, 
respectively. A total of 7695, 4652, and 2948 frames were collected for (1), (2) and (3) 
respectively.  
Integration and reduction of the collected data were performed with the CrysAlisPro software 
package.18 All crystals were cooled to 100K with an Oxford Cryosystems COBRA cooler. 
The unit cell parameters for (1) were refined from 25496 reflections in the monoclinic space 
group P21/c with Z = 4, F(000) = 532 and µ = 0.303 mm-1. The unit cell parameters for (2) 
were refined from 13073 reflections in the monoclinic space group P21/c with Z = 4, F(000) 
= 376 and µ = 0.248 mm-1. The unit cell parameters for co-crystal (3) were refined from 
35677 reflections in the triclinic space group P  with Z , F(000) = 688 and µ = 0.394 mm-1. 
Refer to Table 1 for selected crystallographic information from the independent atom model 
(IAM) and multipole (EXP and SH_D) refinements.  
 1 2 3 
Formula C15H13N3O4S C7H5NO3S C22H18N4O7S2 
Molecular Mass 331.34 183.18 514.52 
Crystal size (mm) 0.25 x 0.20 x 0.20 0.30 x 0.25 x 0.20 0.25 x 0.25 x 0.20 
Temperature (K) 100 100 100 
1
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Crystal system Monoclinic Monoclinic Triclinic 
Space group P21/c P21/c P  
a (Å) 7.034(1) 9.445(1) 9.513(1) 
b (Å) 14.989(1) 6.922(1) 10.393(1) 
c (Å) 13.894(1) 11.686(1) 12.666(1) 
α (o) 90 90 66.968(1) 
β (o) 96.38(1) 103.06(1) 71.02(1) 
γ (o) 90 90 89.369(1) 
Volume (Å3) 1455.90(1) 744.30 (1) 1079.93(2) 
Z 4 4 2 
Refinement Method Full-matrix least 
squares on F2 
Full-matrix least 
squares on F2 
Full-matrix least 
squares on F2 
No. of reflections collected 198191 170313 298222 
No. unique 16911 8965 33446 
Rint 0.045 0.029 0.038 
Completeness (%) 95.8 99.8 94.6 
No. reflections used 14742 7800 35677 
ρc (g cm-3) 1.512 1.635 1.582 
F(000) 688 376 532 
µ (mm-1) 0.248 0.394 0.303 
sin θ/λmax  1.11 Å
-1 1.11 Å-1 1.28 Å-1 
θ range for data collection 
(°) 
2.718 to 65.67 3.445-65.623 2.920 to 65.651 
Index ranges -17≤h≤18  
-38≤k≤38  
-34≤l≤35 
-23≤h≤24  
-17≤k≤17  
-29≤l≤29 
-24≤h≤24  
-24≤k≤24  
-32≤l≤32 
IAM Refinement    
Final R1, wR2 0.034, 0.097 0.022, 0.072 0.038, 0.115 
    
Goodness of fit  1.045 1.094 1.113 
Residual density (e Å-3) -0.739, 0.829  -0.437, 0.623  -0.600, 0.510 
    
Multipole Refinement    
Nobs/Nvar    
 Exp  
Shade 
24.1 
24.3 
24.3 
24.3 
29.7 
29.7 
R(F), R(F2), all data    
ExpShade 0.021, 0.031 
0.031, 0.032 
0.0150, 0.024 
0.0150, 0.024  
0.024, 0.024 
0.0250, 0.0250 
Rw(F), Rw(F2) > 2σ(F)    
 Exp 
Shade 
0.023, 0.045 
0.026, 0.050  
0.011, 0.022 
0.011, 0.022  
0.017, 0.033  
0.018, 0.033 
Goodness of fit    
1
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Exp Shade 1.707 
1.696 
3.058 
3.063 
2.520 
2.536 
Residual density (e Å-3)    
Exp  
Shade 
-0.25 to 0.27 
-0.32 to 0.28 
-0.26 to 0.17 
-0.27 to 0.19 
-0.11 to 0.10 
-0.11 to 0.11 
    
    
 
Table 1: Selected Crystallographic Information for complexes (1) (piroxicam), (2) (saccharin) 
and (3) (piroxicam-saccharin co-crystal). 
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Experimental 
Data reduction and refinement strategies  
The structures of (1), (2) and (3) were solved using direct methods (SHELXS-2014).19 In 
each case, a full-matrix least-squares refinement based on F2 was performed using SHELXL-
2014.19 The bond lengths between non-hydrogen atoms to hydrogen atoms (X-H bonds, 
where X=C, O, N) were fixed at average values obtained from neutron diffraction studies, 
taken from Allen et al.,20 O−H, N−H, and C−H bond lengths being 0.967, 1.009, and 1.083 Å 
respectively, with bond vectors taken from the original riding H-atom models in the IAM 
refinement. All non-hydrogen atoms were refined anisotropically. 
The coordinates and anisotropic temperature factors from the IAM were then imported into 
XD,21 a program that uses a least-squares procedure to refine a rigid pseudo-atom model in 
the form of the Hansen-Coppens multipole formalism.22 In this formalism, the electron 
density, ρ(r) within a crystal is described by the summation of aspherical pseudoatoms (each 
with its own electron density) with nuclear positions rj as shown in the Equation (1).  
         (1) 
The complete density of the pseudo-atomic model is modelled by Equation (2).  
 (2) 
The expression for the pseudo-atom density includes the usual spherical core, a term to 
describe the spherical component of the valence density, plus a deformation term describing 
the asphericity of the valence density. The radial functions {Rl(rj)} are modulated by angular 
functions {dlmp(θj ,Φj)} defined by axes centred on each atom. A number of radial functions 
may be used, the most common being Slater-type functions given in Equation (3). 
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         (3) 
The multipole refinement process began with an analysis of the results of higher order 
spherical atom refinement (usually sin θ/λ > 0.7 A-1), providing accurate atomic positions and 
temperature factors forming the basis for the remainder of the refinement.  
It has been shown that third row atoms are often inadequately modelled by the standard nl-set 
of (4,4,4,4,4), mainly due to the fact that these were originally modelled using node-less 
single-zeta functions to model the valence density. The coefficients nl are chosen so that the 
maximum of the radial function is at the peak density position for each shell. We and others 
have previously shown that this standard description is particularly troublesome for sulfur23-25 
and usually results in high residual electron density in the proximity of the sulfur atoms at the 
completion of the refinement. To address this issue we adopted a model where the nl-set for 
sulfur used in this work was (4,4,4,5,5)26. Additionally, optimisation of the sulfur core 
electron density distribution was introduced by assigning a spherical expansion/contraction 
coefficient (κ′), to the 1s, 2s and 2p electrons, which was allowed to refine. The value of ζ for 
sulfur was that of the free atom (7.278 Å-1)27. 
The refinement was performed by introducing the multipole expansion in a stepwise manner, 
ultimately being truncated at the octapole level (lmax = 3) for C, O, N and S. Each C, O, N 
and S atom was assigned a kappa prime (κ′, a spherical function which governs 3D 
directional expansion/contraction of the valence shell) during the refinement to allow for 
accurate modelling of electron density, and finally a κ′′ value, which models radial 
expansion/contraction of the valence electrons. The density of hydrogen atoms was modelled 
using a single monopole, with κ′ fixed at 1.2, with the aspherical density modelled by a single 
bond-directed dipole (lmax = 1). The refinements were continued until convergence was 
reached for each multipole before the next one was introduced. The Hirshfeld rigid bond test 
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was used to determine if the anisotropic displacement parameters were of any actual physical 
significance; i.e., the electron density was successfully deconvoluted from the inherent 
thermal smearing.28 This test measures the differences in mean-squared displacement 
amplitudes (DMSDA) with ADPs deemed to be described as physically meaningful if they 
are below 1 x 10-3 Å2. The average value obtained from these refinements is 4 x 10-4 Å2. 
Scale and temperature factors were refined separately from the multipole models described 
above, except in the final refinement cycles, where the full variance-covariance matrix is 
needed in order to get meaningful standard uncertainties (su). In all cases, reflections were 
required to have an intensity of F > 3σ(F) in order to be included in the refinement. This 
model is termed EXP in the remainder of the manuscript. 
 
Anisotropic Temperature Refinement of Hydrogen Atoms  
An alternative multipole refinement was carried out using anisotropic temperature factors for 
the hydrogen atoms as well as the heavy atoms, as discussed by Hoser et al.29 regarding the 
increased accuracy of the multipole model obtained from multipole refinement involving the 
use of anisotropic temperature factors for hydrogen.29, 30 Anisotropic temperature factors for 
the hydrogen atoms were calculated using the SHADE3 server developed by Madsen.31 
Multipole analyses with anisotropic temperature factors for hydrogen were truncated at the 
same level as above ((lmax = 3) for heavy atoms and up to the (lmax = 1) for hydrogen 
atoms). The multipole refinement for hydrogen atoms was stopped at the dipolar expansion as 
the observations reported by Nguyen et al.9 illustrated that refinement of hydrogen atoms in 
the multipole model past the dipolar to the quadrupolar level was generally unnecessary and 
would not lead to improved modelling of the electron density. However, it should be noted 
that the decision to refine hydrogen atoms anisotropically should be made on a per case basis. 
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Refer to Table S1 in supplementary data for the anisotropic displacement parameters used. 
This model is termed Shade in the remainder of this manuscript. 
 
Computational Methods  
Gas phase, single point (SP) calculations were performed on (1), with the geometry taken 
from the high-order experimental coordinates. Geometry optimisation (OPT) as well as SP 
calculations were also performed on all structures. All theoretical calculations were 
performed with the Gaussian 09 suite32 at the 6-31+G(d,p) level of theory for all structures. 
All calculations used the three-parameter hybrid exchange function developed by Becke33 in 
conjunction (vide supra) with the exchange correlation potential, corrected via gradient 
developed by Lee et al.34 (B3LYP). Analysis of the topology of electron density from the 
experimental model was performed using the XDPROP portion of XD,21 while analysis of the 
electron density for the theoretical densities was performed using the AIMALL35 package.  
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Results and Discussion 
Geometry 
Bond lengths and angles for all experimental structures were obtained from the multipole 
model (MM) refinement output, while bond lengths for the theoretical structures were 
obtained from DFT optimisation.32 For (1), the X-ray structure was in excellent agreement 
with results reported by Koji-Prodic et al36 in 1982, and also correlate well with the optimised 
geometry model (OPT), with mean differences of 0.006 Å and 0.4° for bond lengths and 
angles, respectively. A similar situation was also seen for (2), where the geometrical details 
obtained from IAM refinement were in good agreement with the bond lengths and angles 
reported by Bart in 196813 with mean differences of  0.008 Å  for bond length and 0.01° for 
angles, respectively. Comparison between the MM structure and DFT optimisation of (2) 
revealed that bond lengths and angles differed by an average of 0.010 Å and 0.05°, 
respectively. For complex (3), our data are in good agreement with values reported by Bhatt 
et al. in 200537 with mean differences of only 0.008 Å for bond lengths and 0.06° for angles. 
Interestingly, (3) is made up of a single molecule of saccharin, and a zwitterionic piroxicam, 
where the hydroxyl hydrogen (H3A) from O(3) is now found on the pyridyl nitrogen atom 
N(3). This has the effect of rotating the pyridyl group approximately 180° around the N(2) – 
C(10) bond compared to (1), and forms an intramolecular hydrogen bond with the amide 
oxygen atom O(4). Refer to Tables S2 – S5 in supplementary data for a comparison of 
experimental and theoretical bond lengths and angles.  
 
 
Sulfur core optimisation 
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As outlined above, it was necessary to optimise the standard description of sulfur in this 
refinement. Each sulfur atom (in each compound) was split so that the core shells (1s2, 2s2, 
2p6) has a spherical expansion/contraction coefficient (κ) and a fixed population, while the 
valence shell (3s2, 3p4) had both spherical and aspherical κ values, as well as population 
refined. The suitability of this model is demonstrated in Table 2, where maximum and 
minimum residual errors are significantly smaller in most cases than those obtained from the 
standard model for sulfur. This is most evident in 3, where residuals of as much as -0.41 and 
+0.32 e Å-3 are reduced to -0.11 and 0.10 e Å-3, where all such peaks and troughs are located 
within 1 Å from S nuclei. 
Table 2 details the results of the refined κ values for the sulfur atoms in all three structures, 
along with the associated monopole populations. For (1), in a standard MM refinement, both 
the spherical and aspherical components of the valence density are expanded, when compared 
to that of the free atom. However, when a core optimised approach is taken, the radial 
behaviour of the valence density changes and is essentially equal to that of the free atom. 
Interestingly, in (2), the situation is somewhat different, despite the similar chemical 
environment of the sulfonyl group. Here the valence density is contracted, as is the aspherical 
component, when compared to the free atom. For (3), the situation is similar to that in (1), 
with spherical components of both core and valence electron density expanded, while the 
aspherical density is slightly expanded. We notethat κ in the standard refinement settles at a 
very unrealistic value of 1.6. For the core optimised refinement, the valence population of 
sulfur is maintained across (1) and both molecules in (3) at an average of 5.6 e, whereas the 
same atom in (2) having a population that surprisingly differs by approximately 1e at 4.7 e.   
 
Atom Label Kappa´ Kappa´´ Population (e) R(F) Max/Min 
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Residual 
e Å-3 
Piroxicam (1)      
S(1)valence 0.9498 1.0002  5.8561   
S(1´)core 0.9846 1.0000 10.0000 0.0219 0.27/-0.25 
 (0.9876) (0.9746) (5.7451) (0.0217) (0.34/-0.37) 
Saccharin (2)      
S(1)valence 1.0539 1.0119  4.7348   
S(1´)core 1.0300 1.0000 10.0000 0.015 0.27/-0.25 
 (1.0447) (0.9629) (4.5679) (0.015) (0.26/-0.35) 
Co-crystal (3)      
Piroxicam      
S(1´A)valence  0.9751 1.0649  5.5666   
S(1´B)core 0.9414 1.0000 10.0000 0.021 0.10/-0.11 
 (1.0437) (1.6286) (4.7051) (0.027) (0.32/-0.41) 
Saccharin      
S(1A)valence  0.9751 1.0649  5.5438   
S(1B)core 0.9414 1.0000 10.0000   
 - - (4.5193)   
Table 2 – Expansion/contraction coefficients (kappas) for sulfur. Values in parentheses refer 
to a standard un-optimised (4,4,4,4,4) refinement. 
 
Isotropic vs. Anisotropic Refinement of Hydrogen Atoms  
The temperature factors of hydrogen atoms were anisotropically modelled based upon 
discussions by Hoser et al.,29 Spackman et al.38-40 and Koritsansky et al.41 These studies have 
observed dissimilarities in the topological analysis of weak interactions such as H-bonds , van 
der Waals forces and π- π stacking interactions.30 To observe the effect of applying calculated 
anisotropic temperature factors for hydrogen atoms during multipole refinement, anisotropic 
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temperature factors were calculated31  and the resulting ADPs transferred to the multipole 
model. Hirshfield’s rigid bond test was applied and the mean DMSDA values for the Exp 
refinement were 1.21 x 10-4, 1.56 x 10-4 and 1.85 x 10-4 Å2 for (1), (2) and (3), respectively. 
Similarly, the DMSDA values for the Shade refinement were 1.20 x 10-4, 1.58 x 10-4 and 1.92 
x 10-4 Å2. All mean DMSDA values are below 1 x 10-3 Å2, indicating that the ADPs 
(including hydrogen atoms) employed in the multipole refinements had sufficiently 
accounted for the thermal motion of the atoms. As shown in the graphs in the supplementary 
material (Figures Sx-y), Exp and Shade refinements show generally good agreement across 
most of the H-bonds. The main differences between Exp and Shade analyses were seen in the 
weak (EHB < 20 kJ mol-1) or strong H-bonds (EHB > 60 kJ mol-1), and bonds with intermediate 
energy values being essentially identical. Both observations are in accordance with those 
reported by Nguyen et al.9 Our findings show that the use of anisotropic temperature factors 
in hydrogen atom refinement provides no significant difference in topology, (both intra- and 
intermolecular); and the application of ADPs to hydrogen atoms is deemed unnecessary in 
this case; thus the discussion will focus on the isotropic hydrogen atom model. 
 
Topological Analysis  
Topological analysis of both the theoretical and experimental structures density was carried 
out and completeness of the analysis was ensured through satisfaction of the Poincaré-Hopf 
or its crystalline equivalent Morse relationship.42 Intramolecular BCPs corresponding to all 
expected covalent bonds are found in the analysis of all complexes: refer to Supplementary 
Data Table S6-7 for details of the full topological analysis. There is generally a good 
correlation between ρbcp and ∇2ρbcp values obtained from the Exp and SP densities for all 
complexes, shown through the small differences in ρbcp and ∇2ρbcp For (1) and (2), in non- S-
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O bonds, average differences of -0.05 and -0.02 e Å-3 and 3.52 and -1.32 e Å-3 were seen for 
ρbcp and ∇2ρbcp, respectively. For (3), there was a mean difference for non- S-O bonds of 0.07 
and 0.59 e Å-3 for ρbcp and ∇2ρbcp between experiment and theory. Laplacian plots for (1), (2) 
and (3) are shown below (Figures 5 a,- f). 
In the S–O bonds, however, agreement between experiment and theory is poor (Table 3). For 
(1) the largest differences seen are in the topology of the sulfonyl bonds; DFT underestimates 
ρbcp by 0.34 e Å-3 in S(1) – O(1), and overestimates this quantity in S(1) – O(2) by 0.1 e Å-3.  
Even larger differences in ∇2ρbcp are found, where DFT overestimates this value by between 
12 and 27 e Å-3. For (2), the effect on the Laplacian sulfonyl bonds is far more pronounced, 
and differences in ∇2ρbcp values between experiment and DFT for the S=O bonds were as 
much as 40 e Å-3. In (3), the maximum difference is again seen in the S1′-O2′ bond, for 
which a discrepancy of 30 e Å-3 is seen in ∇2ρbcp.  The large discrepancies here may be 
attributed to the inability of the experimental model to properly account for the valence 
electrons of heavy atoms such as sulfur, further compounded by the proximity of two oxygen 
atoms which may also contribute to a large amount of unaccounted for electrons.  
 
	   ρ	  (e	  Å-­‐3)	   ∇2ρ	  (e	  Å-­‐5)	   ε	  	  
Piroxicam	  (1)	   EXP	   SH_D	   SP	   	  	   EXP	   SH_D	   SP	   	   EXP	   SH_D	   SP	   	  
S(1)	  -­‐	  O(1)	  	   2.39	   2.38	   2.05	   	  	   	  	  1.48	   	  	  1.65	   28.93	   	   0.17	   0.16	   0.01	   	  
S(1)	  -­‐	  O(2)	  	   1.96	   1.96	   2.05	   	  	   	  15.86	   	  15.99	   29.77	   	   0.21	   0.20	   0.03	   	  
	  Saccharin	  (2)	   	  	   	  	   	  	   	  	   	  	   	  	   	  	   	   	  	   	  	   	  	   	  
S(1)	  -­‐	  O(1)	   	  2.26	   2.26	  	   	  2.01	   	  	   	  -­‐5.47	   	  -­‐5.25	   	  32.42	   	   	  0.08	   0.08	  	   0.07	  	   	  
S(1)	  -­‐	  O(2)	   	  2.27	   	  2.27	   2.01	   	  	   	  -­‐7.71	   	  -­‐7.48	   	  32.65	   	   0.06	  	   0.06	   0.07	   	  
Piroxicam	  (3)	   	   	   	   	   	   -­‐	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S(1’)	  -­‐	  O(1’)	   2.31	   2.29	   2.00	   	  	   -­‐7.75	   -­‐6.37	   32.24	   	   0.07	   0.07	   0.03	   	  
S(1’)	  -­‐	  O(2’)	   2.31	   2.20	   1.98	   	  	   -­‐0.62	   0.12	   32.14	   	   0.19	   0.19	   0.01	   	  
Saccharin	  (3)	   	   	   	   	   	   	   	   	   	   	   	   	  
S(1)	  -­‐	  O(1)	   1.90	   1.88	   2.00	   	  	   25.44	   26.86	   32.82	   	   0.38	   0.37	   0.07	   	  
S(1)	  -­‐	  O(2)	   2.38	   2.37	   2.00	   	  	   -­‐10.38	   -­‐9.85	   32.13	   	   0.09	   0.10	   0.07	   	  
Table 3: Sulfur – Oxygen topology in (1), (2) and (3). 
 
DFT universally predicts large, positive values of ∇2ρbcp, indicative of closed-shell 
interactions, whereas experiment finds no such fixed pattern. However, interpretation of such 
values has been shown to be complicated by the rapidly changing nature of ∇2ρ in such polar 
covalent bonds, where the BCP is often located close to the point where ∇2ρ changes sign. As 
shown in Figure 5, Laplacian diagrams for S=O bonds in each of the complexes show a clear 
overlap of the valence shell charge concentration, resulting in what appears to be open shell 
interactions, albeit with a severe pinching off in the S(1) O(2) bond in saccharin. These 
discrepancies are commonly seen in polar bonds such as these, and can be explained by the 
experimental density changing more quickly than the theoretical counterpart43. This 
phenomenon is also seen when the electron density and Laplacian of the S=O bonds are 
plotted against bond length. It can be seen that the electron density for both EXP and DFT 
follow a similar pattern, however a different story is seen in the Laplacian, with the EXP 
showing significant closed shell interactions as seen through the highly negative values of the 
Laplacian in the EXP model. In contrast, the DFT models graphed along the same axes show 
significantly less negative Laplacian highlighting an open shell interaction more indicative of 
covalent bonding. Complete graphs of the electron density and Laplacian can be found in 
Supplementary Information Figure S1-2. 
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 Thus, very small differences in the total electron density, of the same magnitude as the 
residual errors stemming from the multipole model, are amplified in the Laplacian into 
apparently major discrepancies between experiment and theory23, 24, 43. It should be noted here 
that there is no appreciable difference between the Exp and the Shade refinements, across all 
datasets the maximum differences are 0.30eÅ-3 for ρbcp and -1.5 eÅ-5 in ł2ρbcp.  
(a)
 
(b)
 
(c)
 
(d)
 
(e) 
 
(f) 
 
Figure 5: Exp -ł2ρbcp distribution of the O(1) – S(1) – O(2) plane for piroxicam in (a) (1), (b) 
(2), (c) (3), (d) saccharin in (3), and (e) theoretical for piroxicam in (3), and (f) saccharin in 
(3). The theoretical Laplacian plots of individual molecules in (1) and (2) show no 
appreciable differences from plots in (e) and (f) and are thus not shown. 
 
As well as considering agreement with DFT, Table 3 shows that even within a single 
molecule there are significant differences between S-O bonds depending on their 
environment. Geometrical considerations suggest that (1) contains a hydrogen bond from 
O(2) to a symmetry-related H(2)-N(2) group (N…O = 3.002 Å). (3) contains a hydrogen 
bond from O(2′) to symmetry-related H(3′)-N(3′) (N…O = 3.015 Å), and also from O(2) to 
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symmetry-related H(3′)-N(3′) (N…O = 3.048 Å). In contrast, (2) contains no hydrogen bonds 
with S-O groups as H-bond acceptors. Table 3 indicates that (1) and (3) exhibit marked 
differences in the topology of S-O bonds, whereas those in (2) are almost identical. This leads 
us to suspect that the effects of the crystalline environment are at least partly responsible for 
the patterns observed in Table 3, a possibility that is explored in more detail using the EDD 
below. 
 
Hydrogen Bonds  
A total of 9, 5 and 12 classical hydrogen bonds were found for (1), (2) and (3), respectively. 
Topological details of the corresponding BCPs for are reported in Table 4 with details of the 
SHADE refinement removed for clarity. The full table can be found in Supplementary Data 
Table S9, and geometrical details can be found in Supplementary Data Table S8. The bonds 
found include those with traditional donors and acceptors (such as N – H  and O – H to O and 
N), and also those validated by Koch et al44 of the form C-H···O and C-H···π contacts. 
Analysis of the bonds showed that N-H···C and N-H···O arrangements were the most linear, 
while the least linear H-bonds are N-H···O, O-H···N and C-H···O bonds. It was also found 
that C-H···C and C-H···O bonds had the largest distance between the hydrogen and acceptor 
atoms, while N-H···O bonds had the shortest distance. No notable correlations were found 
between donor to acceptor lengths for the different types of H-bond, with (1) having the 
longest donor to acceptor length in bonds where the acceptor group was C-H, followed by O-
H and N-H donor groups. For (2), a converse pattern was found with N-H groups having the 
longest donor to acceptor bond length. It should be noted for all of the above cases, that 
different H-bond lengths, even for those with the same donor and acceptor groups is normal 
due the crystal field effect, especially in the case of (1) where intermolecular H-bonds within 
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the same asymmetric unit would in most cases be shorter than those which extend to 
molecules in other asymmetric units or unit cells.  
Hydrogen bonds according to Koch et al.44 are characterised by relatively low ρbcp and 
positive ∇2ρbcp. Topological analysis of H-bonds was performed for both the Exp and Shade 
models, while intramolecular H-bonds and those in? a discrete dimer of the co-crystal from 
experimental coordinates, were also analysed via DFT. For (1), three intramolecular H-bonds 
were found in both the experimental and theoretical analyses, with a further six 
intermolecular hydrogen bonds located between neighbouring molecules. For (3), three of the 
bonds found were considered to be within the asymmetric unit between the piroxicam and 
saccharin molecules. Figure 6 shows the weak interactions present in the co-crystal (3). 
 
Dissociation energies of the hydrogen bonds were calculated by applying the methods of 
Abramov 45 and Espinosa46; topological parameters such as electron density could be used to 
estimate the kinetic, potential and total energy densities related to a bond, and hence to 
estimate the strength of a hydrogen bond. The ratio –G/V can also be used to estimate 
covalency in H-bonds: a value of between 0.5 and 1 indicates partly covalent character, while 
a value of greater than 1 is considered to be purely non-covalent47.  H-bonds can be separated 
into three groups by their strengths; weak H-bonds (EHB < 20 kJ mol-1), moderate strength H-
bonds (EHB = 20-40 kJ mol-1) and strong H-bonds (EHB > 60kJ mol-1). In (3), two 
intramolecular and one intermolecular contacts are considered to be strong hydrogen bonds, 
with the remainder considered to be weak H-bonds or π…π contacts. Similar trends can be 
seen in (1) and (2), with the majority of the H-bonds being classified as weak (six for (1) and 
four for (2), two of the H-bonds in (1) being of moderate strength and the rest in both being 
considered to be strong.  
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 ρ  
/ eÅ-3 
∇ 2ρ  
/ eÅ-5 
ε  G 
/ Eh eÅ-3 
V 
/  Eh eÅ-3 
H 
/  Eh eÅ-3 
EHB 
/ kJ mol-
1 
Intermolecular        
N(2)–H(2A)	  ···	  O(2) 0.073 1.248 0.33 0.07 -0.05 0.02 19.45 
C(5)	  –	  H(5)	  ···	  O(2) 0.049 0.750 0.43 0.04 -0.03 0.01 11.67 
C(5)	  –	  H(5)	  	  ···	  O(1) 0.045 0.739 0.53 0.04 -0.03 0.01 11.67 
C(14)	  –	  H(14)	  ···	  O(4) 0.012 0.437 2.27 0.02 -0.01 0.01 3.89 
C(15)	  –	  H(15A)	  ···	  O(1) 0.039 0.672 0.09 0.03 -0.02 0.01 7.78 
C(15)	  –	  H(15B)	  ···	  O(1) 0.047 0.743 0.11 0.04 -0.03 0.01 11.67 
Intramolecular        
N(2)	  -­‐	  H(2A)	  ···	  N(1) 0.166 2.185 1.91 0.14 -0.13 0.01 50.57 
O(3)	  -­‐	  H(3A)	  ···	  O(4) 0.362 5.038 0.03 0.38 -0.41 0.01 159.51 
C(11)	  -­‐	  H(11)	  ···	  O(4) 0.119 1.606 0.14 0.10 -0.08 0.01 31.12 
Close Contacts        
C(3)…C(12) 0.034 0.313 0.46 0.02 -0.01 0.00 3.89 
C(4)…C(10) 0.037 0.359 3.56 0.02 -0.01 0.01 3.89 
C(5)…C(9) 0.036 0.343 0.48 0.02 -0.01 0.00 3.89 
H(12)…H(6) 0.013 0.599 0.13 0.03 -0.02 0.01 7.78 
H(11)…H(15C) 0.024 0.323 0.47 0.02 -0.01 0.01 3.89 
Table 4 Topological analysis of hydrogen bonding in (1). Standard uncertainties have been omitted 
from the table for clarity. They are closely scattered around 0.02 e Å-3 (ρ bcp) and 0.05 e Å-5 (∇2ρ bcp). 
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 ρ  
/ eÅ-3 
∇ 2ρ  
/ eÅ-5 
ε  G 
/ Eh eÅ-3 
V 
/  Eh eÅ-3 
H 
/  Eh eÅ-3 
EHB 
/ kJ mol-
1 
Intermolecular        
N(1)–H(1A)	  ···	  O(3) 0.20 3.61 0.00 0.23 -0.20 0.03 77.81 
C(2)	  –	  H(2)	  ···	  O(2) 0.04 1.00 0.42 0.05 -0.03 0.02 11.67 
C(3)	  –	  H(3)	  	  ···	  O(2) 0.05 0.65 0.04 0.04 -0.03 0.01 11.67 
C(4)	  –	  H(4)	  ···	  O(1) 0.05 0.73 0.14 0.04 -0.03 0.01 11.67 
C(5)	  –	  H(5)	  ···	  O(3) 0.07 0.96 0.03 0.05 -0.04 0.01 15.56 
Close Contacts        
C(7)	  ···	  C(5) 0.03 0.33 1.49 0.02 -0.01 0.00 3.89 
O(1)	  ···	  C(7) 0.04 0.46 1.06 0.03 -0.02 0.01 7.78 
O(1)	  ···	  C(6) 0.04 0.46 1.06 0.03 -0.02 0.01 7.78 
Table 5 Topological analysis of hydrogen bonding in (2). Standard uncertainties have been omitted 
from the table for clarity. They are closely scattered around 0.02 e Å-3 (ρ bcp) and 0.05 e Å-5 (∇2ρ bcp).	  
 ρ  
/ eÅ-3 
∇ 2ρ  
/ eÅ-5 
ε  G 
/ Eh eÅ-3 
V 
/  Eh eÅ-3 
H 
/  Eh eÅ-3 
EHB 
/ kJ mol-
1 
Intermolecular        
N(1)–H(1A)	  ···	  O(3’) 0.32 4.23 0.05 0.32 -0.34 -0.02 132.28 
N(3’)	  –	  H(3A’)	  ···	  O(2’) 0.07 0.89 0.32 0.05 -0.04 0.01 15.56 
C(3)	  –	  H(3)	  	  ···	  O(4’) 0.05 0.72 0.35 0.04 -0.03 0.01 11.67 
C(3)	  –	  H(3)	  ···	  N(1’) 0.03 0.77 1.04 0.04 -0.02 0.02 7.78 
C(4)	  –	  H(4)	  ···	  O(2’) 0.06 0.88 0.06 0.05 -0.03 0.01 11.67 
C(5’)	  –	  H(5’)	  ···	  O(2) 0.04 0.90 0.46 0.05 -0.03 0.02 11.67 
C(11’)	  –	  H(11’)	  ···	  O(3) 0.05 1.29 0.29 0.07 -0.04 0.02 15.56 
C(12’)	  –	  H(12’)	  ···	  O(1) 0.06 0.67 0.08 0.04 -0.03 0.01 11.67 
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C(14’)	  –	  H(14’)	  ···	  O(2) 0.04 0.52 0.33 0.03 -0.02 0.01 7.78 
C(15’)	  –	  H(15C)	  ···	  
O(3) 
0.05 0.84 0.11 0.04 -0.03 0.01 11.67 
Intramolecular        
N(2’)	  -­‐	  H(2A’)	  ···	  O(3’) 0.29 3.94 0.04 0.29 -0.30 -0.01 116.71 
  DFT        
N(3’)	  -­‐	  H(3A’)	  ···	  O(4’) 0.23 3.07 0.17 0.21 -0.21 0.00 81.70 
  DFT        
Close Contacts        
C(1’)	  ···	  C(4)	  –	  π 	  ···	  π  0.03 0.30 0.39 0.02 -0.01 0.00 3.89 
C(2’)	  ···	  C(11’)	  –	  π 	  ···	  π  0.04 0.34 0.22 0.02 -0.02 0.00 7.78 
C(4’)	  ···	  C(13’)	  –	  π 	  ···	  π  0.04 0.36 0.35 0.02 -0.02 0.00 7.78 
C(4)	  	  ···	  N(2’) 0.03 0.31 1.09 0.02 -0.01 0.00 3.89 
C(5)	  ···	  O(3’)	  –	  π 	  ···	  C=O 0.03 0.34 0.83 0.02 -0.01 0.01 3.89 
C(6’)	  ···	  H(15B) 0.04 0.41 0.74 0.02 -0.02 0.01 7.78 
C(7’)	  ···	  H(15B) 0.04 0.41 0.74 0.02 -0.02 0.01 7.78 
C(11’)	  ···	  C(2) 0.03 0.31 1.63 0.02 -0.01 0.00 3.89 
C(7)	  ···	  C(7) 0.06 0.70 3.18 0.04 -0.03 0.01 11.67 
C(7)	  ···	  O(3)	  -­‐	  -­‐	  C=O 0.06 0.70 3.18 0.04 -0.03 0.01 11.67 
H(4’)	  ···	  H(1A) 0.03 0.34 0.83 0.02 -0.01 0.01 3.89 
Table 6 Topological analysis of hydrogen bonding in (3). Standard uncertainties have been omitted 
from the table for clarity. They are closely scattered around 0.02 e Å-3 (ρ bcp) and 0.05 e Å-5 (∇2ρ bcp). 
 
Atomic Charges 
As mentioned previously, in (3) the piroxicam moiety is found as the zwitterion (Figure 8), 
such that nature of the ionisation/charge on the oxygen and nitrogen and associated functional 
groups should be seen in the charge distribution. The monopolar electron population (Pv) was 
determined for each atom in (1) and (2), and was compared to each atom in (3). Surprisingly, 
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the average difference of atomic charges within piroxicam molecules in (1) and (3) is just 
0.004 e, with the greatest difference of +0.28 e seen in H2A, i.e., the hydrogen located on 
amide nitrogen. For saccharin the average difference between (2) and (3) was more 
pronounced, albeit on average very small, with an average of -0.02 e, with the greatest 
change seen in S(1) of -0.71 e when compared to its counterpart in (3). In both molecules, 
differences of around 0.2 e were seen consistently across the sulfonyl oxygen atoms, with 
those in (3) being the more negative; this is possibly due to the large number of weak 
interactions in the co-crystal.  
 
 
Figure 8: Zwitterionic structure of piroxicam in (3). 
Somewhat surprisingly, the groups bearing formal positive and negative charges in (3) show 
very small changes from their charges in pure crystalline forms. For the phenolic O(3) – 
H(3A) group, there was very small change from (1) to (3), with H(3A) becoming slightly 
more negative in (3), by 0.08 e. The pyridyl nitrogen atom N(3), also had an insignificant 
change in monopolar charge, becoming more negative -0.01 e. The lack of localised 
monopole charges in zwitterionic compounds has been observed in experimental charge 
density studies previously,23 and it is generally found that the changes in charge are 
‘delocalised’ across neighbouring atoms.  
S
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H
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To examine this phenomena, piroxicam was partitioned into three distinct groups (Table 7), 
and the combined charges of atoms in each of these groups determined. This data shows that, 
whether charges are determined from refined monopole values (Pv) or integration over 
atomic basins (Ω), the change from (1) to (3) leads to the benzothiazinedioxide fragment (A) 
becoming substantially more negative and the pyridyl (B) and amide (C) groups becoming 
positive. Theoretical values, however, do not agree with this pattern, presumably due to the 
lack of crystalline environment in DFT calculations, and so are omitted from Table 7. Thus, 
while individual atoms do not reflect the formal charges in the standard view of the 
zwitterion, fragment values do, indicating that the charges are significantly delocalised over 
entire groups. 
For saccharin, while there is no possibility of forming a zwitterion, there are some equally 
significant changes on co-crystallisation. In a similar fashion to piroxicam, saccharin was 
partitioned into separate molecular fragments, and the charges from experiment and theory 
are also given in Table 7. Here, the sulfurdioxide (D) group becomes more negative by 0.36 
e, and the corresponding positive charge balance has been spread across the amide (E), and 
phenyl (F) groups, these becoming more positive by 0.20 and 0.31e respectively.  
 
Piroxicam	  
	  
(A)	  
	  
(B)	  
	  
(C)	  
	   	   	  Pv	  (1)	   0.39	   0.37	   -­‐0.3	  
	   	   	  Pv	  (3)	   -­‐0.88	   0.63	   0.19	  
	   	   	  
	   	   	   	   	   	   	  Ω(exp)	  (1)	   -­‐0.16	   0.68	   -­‐0.7	  
	   	   	  Ω(exp)	  (3)	   -­‐0.75	   1.09	   -­‐0.36	  
	   	   	  
	   	   	   	   	   	   	  Δ(Pv)	   -­‐1.27	   0.26	   0.49	  
	   	   	  ΔΩ(exp)	   -­‐0.69	   0.37	   0.34	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H
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Saccharin	  
	  
(D)	  
	  
(E)	  
	  
(F)	  
	   	   	  Pv	  (2)	   0.17	   -­‐0.28	   0.01	  
	   	   	  Pv	  (3)	   -­‐0.19	   -­‐0.08	   0.32	  
	   	   	  
	   	   	   	   	   	   	  Ω(exp)	  (2)	   0.40	   -­‐0.47	   -­‐0.01	  
	   	   	  Ω(exp)	  (3)	   0.37	   -­‐0.55	   0.20	  
	   	   	  
	   	   	   	   	   	   	  Δ(Pv)	   -­‐0.36	   0.20	   0.31	  
	   	   	  ΔΩ(exp)	   -­‐0.03	   -­‐0.08	   0.21	  
	   	   	  	   	   	   	   	   	   	  
Table 7 Atomic charges (e) from multipole refinement. 
 
 
 
Electrostatic Potential 
The major changes in EDD that are reflected in atomic charges should also be apparent in the 
molecular electrostatic potential (MEP), one of many chemical properties which can be 
derived from an analysis of electron density.  The MEP is significant in EDD studies of co-
crystal systems as it allows the visualisation of electron density across each molecule within 
the asymmetric unit, thus allowing visualisation of the non-covalent interactions which are 
the driving force in co-crystal formation.16 Figure 9 shows the MEP calculated from the Exp 
refinement of (1), (2) and (3) respectively. MEP plots for isolated molecules exhibit strongly 
negative minima close to O atoms as well as pyridine N, as well as positive values near H-N 
groups and also close to S atoms. Formation of the co-crystal results in significant changes in 
the MEP of (3), broadly following the patterns observed in atomic charges discussed above. 
In particular, strongly positive values are now found in the vicinity of all hydrogens (C-H as 
well as N-H) on the protonated pyridine ring, while the negative MEP associated with the 
formally deprotonated O(3') is substantially more negative in (3) than in (1). 
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(a) 
	  
(b) 
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(c) 
 
Figure 9: Molecular Electrostatic Potential of (1), (2) and (3) mapped onto an isosurface of ρ. 
The colour gradient ranges from 2e/bohr, dark red (electropositive ) through green and blue 
to 32e/bohr, magenta (electronegative). 
 
Conclusions 
We reportean analysis of the experimental electron density distribution of the piroxicam-
saccharin co-crystal, along with equivalent analysis of its pure constituents piroxicam and 
saccharin. The small differences in ρ and ∇2ρ values reported between experimental and 
theoretical studies, as well as the small residual errors that results from the multipole model, 
show that the models employed in the study are robust. Moreover, we found that the 
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introduction of ADPs for hydrogen atoms into the multipole model did not provide any 
improvements to the data obtained from multipole refinement from either of the complexes. 
A detailed investigation into the weak interactions in these systems, and especially the effects 
of co-crystallisation on the EDD and related phenomena within these complexes has been 
carried out. Specific co-crystal forces were assessed, such as the potential stabilising effect 
offered by saccharin, allowing piroxicam to adopt a different amide conformation, as well as 
a zwitterionic state in the co-crystal compared to the single crystal. A comparison of atomic 
charges and molecular electrostatic potential between (1), (2) and (3) confirms that electron 
redistribution occurs during the co-crystallisation process to facilitate the formation of weak 
interactions which in turn stabilise the co-crystal system. Further work in this area will 
involve integration of the information gained from EDD studies with established synthetic 
techniques to engineer favourable weak interaction in order to drive the development of more 
efficacious pharmaceutical co-crystals.  
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